institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published 2 days ago • loading... • Updated 2 days ago

Lilly announces details of presentations at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Summary by Charleston Gazette-Mail

INDIANAPOLIS, May 22, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), olomorasib, an investigational KRAS G12C inhibitor, LY4170156, an investigational antibody-drug conjugate (ADC)…

48 Articles

48 Articles

All

Left

6

Center

16

Right

4

The Conway Daily Sun

+47 Reposted by 47 other sources

Lilly announces details of presentations at 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

INDIANAPOLIS, May 22, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of imlunestrant, an investigational oral selective estrogen receptor degrader (SERD), olomorasib, an investigational KRAS G12C inhibitor, LY4170156, an investigational antibody-drug conjugate (ADC)…

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources48

Leaning Left6Leaning Right4Center16Last Updated13 hours agoBias Distribution

62% Center

Bias Distribution

62% of the sources are Center

62% Center

+11

Untracked bias

+13

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States 2 days ago on Thursday, May 22, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics